Top compounds associated with response to SLAMF9


Feature Type Standardized
Nominal ANOVA
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.1 0.0005
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.001
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.098 0.001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.1 0.002
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.16 0.003
mRNA PLX4720 CCLE pan-cancer AAC 0.14 0.003
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA FH535 GDSC1000 pan-cancer AAC 0.1 0.003
Download CSV